GALT31A Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
GALT31A; B3GALT6; At1g32930; F9L11.10; Beta-1,6-galactosyltransferase GALT31A; Beta-1,3-galactosyltransferase 6; GT31 family galactosyltransferase 1; AtGALT31A
Target Names
GALT31A
Uniprot No.

Target Background

Function
This antibody targets GALT31A, a beta-galactosyltransferase enzyme crucial for the elongation of beta-1,6-linked galactan side chains on arabinogalactan proteins. Its function is essential for embryonic development, specifically progression beyond the globular stage. GALT31A is also involved in type II arabinogalactan biosynthesis, catalyzing the transfer of galactose from UDP-galactose to various arabinogalactan-derived oligosaccharides. Furthermore, GALT31A forms a complex with GALT29A, exhibiting cooperative activity to enhance galactose residue addition at O6 positions on both beta-1,6- and beta-1,3-linked galactans.
Gene References Into Functions
  • Studies demonstrate GALT31A's role in embryonic development beyond the globular stage. PMID: 23837821
Database Links

KEGG: ath:AT1G32930

STRING: 3702.AT1G32930.1

UniGene: At.40035

Protein Families
Glycosyltransferase 31 family
Subcellular Location
Golgi apparatus membrane; Single-pass type II membrane protein.

Q&A

What is GALT31A and why is it significant in plant research?

GALT31A belongs to the GT31 family of galactosyltransferases in plants, specifically positioned in clade I based on phylogenetic analyses. The significance of GALT31A stems from its critical role in plant embryonic development, where mutations in Arabidopsis GALT31A have been found to arrest development at the globular stage. This indicates that the protein and the β-1,3-galactan linkages it catalyzes are crucial for proper plant development . The enzyme functions in the biosynthetic pathway of arabinogalactan proteins (AGPs), which are important cell wall components involved in multiple developmental processes.

How do researchers detect and characterize GALT31A expression?

While there are no GALT31A-specific antibodies mentioned in the search results, researchers typically employ various antibody-based techniques to detect and characterize expression patterns:

  • Western Blotting (WB): This allows for quantitative analysis of GALT31A protein expression in different tissues or under different conditions. A dilution range of 1:500-1:1000 is typically used for galactosyltransferase antibodies .

  • Immunohistochemistry (IHC): This technique enables visualization of the spatial distribution of GALT31A within plant tissues. Typical dilutions range from 1:20 to 1:200, with antigen retrieval using TE buffer (pH 9.0) or citrate buffer (pH 6.0) .

  • Co-expression analysis: Computational approaches using publicly available tools (like atted.jp and genevestigator.com) can identify genes co-expressed with GALT31A, providing insights into its functional networks within plant development pathways .

What are the recommended storage and handling conditions for GALT31A antibodies?

While specific GALT31A antibody storage conditions aren't detailed in the search results, general best practices for galactosyltransferase antibodies include:

  • Storage at -20°C in PBS buffer containing 0.02% sodium azide and 50% glycerol (pH 7.3)

  • Stability for one year after shipment when properly stored

  • Aliquoting may be unnecessary for -20°C storage

  • Some preparations may contain 0.1% BSA for additional stability

These conditions help maintain antibody functionality and specificity for consistent experimental results. When working with antibodies, avoid repeated freeze-thaw cycles and maintain sterile technique to prevent contamination.

How can researchers validate GALT31A antibody specificity for plant research applications?

Validating antibody specificity for GALT31A requires a multi-faceted approach:

  • Knockout/knockdown controls: Testing the antibody against wild-type and GALT31A-deficient samples is the gold standard validation method. The absence of signal in knockout/knockdown samples confirms specificity.

  • Multiple detection methods: Confirming results across different techniques (WB, IHC, ELISA) strengthens confidence in antibody specificity.

  • Fluorescence-activated cell sorting (FACS): While typically used for animal cells, FACS with appropriate modifications can help validate antibody specificity in plant protoplasts. The antibody should bind to cells expressing the target antigen with greater fluorescence intensity compared to negative controls .

  • Peptide competition assay: Pre-incubating the antibody with the immunogen peptide should abolish specific binding if the antibody is truly specific for GALT31A.

  • Cross-reactivity testing: Examining antibody reactivity against closely related GT31 family members, especially from the same clade, is crucial to ensure target specificity.

What experimental approaches can resolve contradictory findings in GALT31A localization studies?

When faced with contradictory data regarding GALT31A subcellular localization:

  • Multi-tag approach: Employ different epitope tags (N-terminal vs. C-terminal) to ensure tag interference isn't causing mislocalization. Compare results from GFP, HA, and FLAG tags to identify consistent localization patterns.

  • Co-localization studies: Use established Golgi markers (where GALT31A is expected to localize based on related galactosyltransferases) like ST-RFP and perform high-resolution confocal microscopy to determine precise subcellular compartmentalization.

  • Biochemical fractionation: Complement imaging with subcellular fractionation and Western blotting to independently confirm the compartment(s) where GALT31A resides.

  • Native vs. overexpression systems: Compare localization of endogenous GALT31A (detected by antibody) with expressed constructs to identify potential artifacts from overexpression.

  • Developmental timing analysis: Examine localization across different developmental stages, as GALT31A function in embryo development suggests its localization might be dynamic during development.

How can researchers optimize immunoprecipitation protocols for studying GALT31A interaction partners?

Optimizing immunoprecipitation (IP) for GALT31A protein interaction studies requires:

  • Crosslinking optimization: Test different crosslinkers (formaldehyde, DSP, DTSSP) at varying concentrations (0.1-1%) and incubation times (5-30 minutes) to preserve transient interactions while maintaining antibody epitope accessibility.

  • Lysis buffer formulation:

    • Test multiple buffer compositions to maintain enzymatic activity:

    Buffer ComponentConcentration RangePurpose
    Tris-HCl (pH 7.5-8.0)20-50 mMMaintains pH
    NaCl100-150 mMProvides ionic strength
    EDTA1-5 mMChelates metal ions
    Triton X-100/NP-400.5-1%Solubilizes membranes
    Glycerol5-10%Stabilizes proteins
    Protease inhibitors1XPrevents degradation
    Phosphatase inhibitors1XPreserves phosphorylation
  • Antibody coupling: For cleaner results, couple antibodies to solid supports (protein A/G beads or magnetic beads) prior to IP rather than adding antibodies directly to lysates.

  • Sequential IP approach: For challenging interactions, consider tandem IP protocols where the first IP enriches for GALT31A, followed by elution under native conditions and a second IP against the suspected interaction partner.

  • Mass spectrometry analysis: Employ high-sensitivity MS/MS techniques with appropriate statistical controls to distinguish true interactors from background proteins.

What are the methodological considerations for analyzing GALT31A enzymatic activity in vitro?

To properly assess GALT31A β-1,3-galactosyltransferase activity:

  • Substrate preparation: Use well-characterized acceptor substrates such as:

    • Synthetic oligosaccharides with defined linkages

    • Partially degraded arabinogalactan proteins (AGPs)

    • Biotinylated acceptor peptides for easier activity monitoring

  • Reaction conditions optimization:

    ParameterRecommended RangeNotes
    Temperature25-30°CPlant enzymes often have lower temperature optima
    pH6.5-7.5Test in 0.5 pH unit increments
    Divalent cations (Mn²⁺, Mg²⁺)5-20 mMEssential cofactors for many glycosyltransferases
    UDP-galactose0.1-2 mMDonor substrate
    Incubation time30-120 minutesEstablish linearity of reaction
  • Activity detection methods:

    • Radioactive assays using UDP-[¹⁴C]galactose with scintillation counting

    • HPLC analysis of reaction products with fluorescent labeling

    • Mass spectrometry to confirm product structure and linkage specificity

    • Coupled enzymatic assays monitoring UDP release

  • Controls and validation:

    • Heat-inactivated enzyme controls

    • Competitive inhibitors of β-1,3-galactosyltransferases

    • Comparison with characterized homologs like GALT1 from clade V

How can flow cytometry be adapted for plant studies involving GALT31A antibodies?

While flow cytometry is traditionally used for mammalian cells, it can be adapted for plant research with GALT31A antibodies:

  • Protoplast preparation: Enzymatically remove plant cell walls using cellulase and macerozyme to create single-cell suspensions suitable for flow cytometry.

  • Antibody labeling optimization: Test both direct (antibody-fluorophore conjugate) and indirect (primary antibody + fluorescent secondary) labeling approaches. For indirect methods:

    • Primary antibody dilutions: 1:100-1:500

    • Secondary antibody dilutions: 1:1000-1:2000

    • Incubation times: 30-60 minutes at 4°C

  • Fluorescence-activated cell sorting (FACS):

    • Use proper gating strategies to isolate cells with high GALT31A expression

    • Analyze fluorescence intensity as cells pass through a laser beam

    • Cells expressing GALT31A-binding antibodies will show greater fluorescence intensity

  • Controls for plant flow cytometry:

    • Unstained protoplasts for autofluorescence baseline

    • Secondary antibody-only controls for non-specific binding

    • Wild-type vs. GALT31A-knockout material to validate specificity

    • Isotype controls to assess non-specific binding

What are the most effective approaches for studying GALT31A function in embryonic development?

To investigate GALT31A's critical role in embryonic development at the globular stage :

  • Conditional knockout strategies:

    • Inducible systems (e.g., estradiol-inducible) to bypass embryo lethality

    • Tissue-specific promoters to limit GALT31A disruption to specific embryonic domains

    • CRISPR-based approaches for precise mutagenesis of catalytic domains

  • Complementation experiments:

    • Expression of GALT31A under native promoter in mutant background

    • Domain swapping with related GT31 family members to identify critical functional regions

    • Introduction of point mutations in key catalytic residues to separate enzyme activity from potential structural roles

  • High-resolution phenotypic analysis:

    • Confocal microscopy with appropriate cell wall, membrane, and cytoskeletal markers

    • Transmission electron microscopy to examine ultrastructural details of arrested embryos

    • Cell lineage tracing to identify earliest developmental abnormalities

  • Biochemical characterization of mutant phenotypes:

    • Glycome profiling to assess changes in cell wall composition

    • Linkage analysis of arabinogalactan proteins in wild-type vs. mutant embryos

    • Metabolite profiling to identify accumulation of precursors or reduction in products

How can researchers integrate GALT31A studies with broader cell wall biosynthesis research?

GALT31A research can be connected to broader cell wall biology through:

  • Co-expression network analysis:

    • GALT31A was identified through co-expression with Golgi-localized exo-β1,3-galactosidases involved in cell expansion and root growth

    • Further network analysis can identify additional components of the biosynthetic pathway

  • Comparative studies across GT31 clades:

    • GALT31A belongs to clade I of the GT31 family

    • Comparative analysis with other characterized members like GALT1 (clade V) and KNS4 (clade II) can illuminate specialized vs. conserved functions

  • Integration with cellulose synthesis pathways:

    • GALT31A and its homolog were named "cellulose synthesis associated glycosyltransferases"

    • Investigation of potential interactions with cellulose synthase complexes

    • Analysis of cellulose microfibril organization in GALT31A mutants

  • Multi-omics approaches:

    • Combine transcriptomics, proteomics, and glycomics to build comprehensive models

    • Correlate GALT31A expression patterns with cell wall composition across developmental stages and tissues

    • Identify potential compensatory mechanisms in response to GALT31A perturbation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.